Drug intelligence / Profile preview

Super Lysine+

Development stage
Phase 4
Lead developer
Quantum Health
Modality
Peptides, Small Molecules
Administration
Oral, Topical
01

Overview

Super Lysine+ is a multi-ingredient nutraceutical formulation primarily indicated for the treatment and prophylaxis of Herpes simplex virus (HSV-1) infections, specifically herpes labialis (cold sores). The therapeutic mechanism is centered on the amino acid L-lysine, which acts as a competitive antagonist against L-arginine. Because HSV requires arginine-rich proteins for efficient replication, a high systemic or local lysine-to-arginine ratio suppresses viral protein synthesis and inhibits viral multiplication. The product line, which includes both oral tablets and topical ointments, typically incorporates synergistic components such as Vitamin C to support collagen formation and tissue repair, along with botanical extracts like Echinacea, Garlic, and Propolis to enhance the host's innate immune response and provide broad-spectrum antimicrobial activity.

Brand names
Super Lysine+Super Lysine Plus
Other names
Superlysine
02

Targets

HSV-1 (Herpes simplex virus type 1)

Beyond the preview

Go deeper on Super Lysine+.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Super Lysine+.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call